Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage, Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05163028
What this trial is testing

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

Who this might be right for
Non Small Cell Lung CancerColorectal CancerPancreatic Cancer+4 more
HUYABIO International, LLC. 42
Testing effectiveness (Phase 2)Study completedNCT01666730
What this trial is testing

Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
Case Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT07480928
What this trial is testing

Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally Advanced or Metastatic Disease
Beijing Biotech 42
Early research (Phase 1)Study completedNCT01145456
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+2 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Ended earlyNCT01739439
What this trial is testing

Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasStage IIB Pancreatic Cancer+1 more
Fox Chase Cancer Center 6
Early research (Phase 1)Study completedNCT02045602
What this trial is testing

Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid TumorsPancreatic Adenocarcinoma
Theriva Biologics SL 42
Not applicableLooking for participantsNCT04406831
What this trial is testing

The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Stage IIIPancreatic Cancer Stage IVPancreatic Ductal Adenocarcinoma+1 more
Nuvance Health 200
Testing effectiveness (Phase 2)Looking for participantsNCT07030257
What this trial is testing

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor MalignanciesColorectal CarcinomaSmall Cell Lung Cancer ( SCLC )+4 more
Tasca Therapeutics 150
Early research (Phase 1)Ended earlyNCT00585845
What this trial is testing

Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment

Who this might be right for
Malignant Epithelial MesotheliomaAdenocarcinoma of the PancreasCarcinoma, Non-Small-Cell Lung+1 more
Anza Therapeutics, Inc. 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT06015659
What this trial is testing

ZN-c3 + Gemcitabine in Pancreatic Cancer

Who this might be right for
Advanced Pancreatic AdenocarcinomaPancreatic CancerPancreatic Ductal Adenocarcinoma
Brandon Huffman, MD 12
Testing effectiveness (Phase 2)Study completedNCT03225989
What this trial is testing

Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer

Who this might be right for
Pancreatic AdenocarcinomaOvarian CancerBiliary Carcinoma+1 more
Lokon Pharma AB 47
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Looking for participantsNCT03175224
What this trial is testing

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRenal Cancer+15 more
Apollomics Inc. 497
Early research (Phase 1)Ended earlyNCT02757391
What this trial is testing

CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors

Who this might be right for
Colorectal AdenocarcinomaMetastatic CholangiocarcinomaMetastatic Colorectal Carcinoma+10 more
M.D. Anderson Cancer Center 1
Very early researchStudy completedNCT02153450
What this trial is testing

Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
Case Comprehensive Cancer Center 8
Large-scale testing (Phase 3)Not Yet RecruitingNCT07138846
What this trial is testing

A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Lepu Biopharma Co., Ltd. 231
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Large-scale testing (Phase 3)UnknownNCT00486460
What this trial is testing

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tel-Aviv Sourasky Medical Center
Testing effectiveness (Phase 2)WithdrawnNCT03127124
What this trial is testing

QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma Metastatic
NantPharma, LLC
Not applicableStudy completedNCT03323489
What this trial is testing

Celiac Plexus Radio-Surgery for Pain Management

Who this might be right for
Advanced CancerPancreas CancerPain
Dr. Yaacov Lawrence 125
Next Page